top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

Publications/Patents/Books/Book Chapters

Publications

​

2024​

​​

  • Choudhuri, T.; Paul, S.; Sikdar, P.; Das, S.; Sawant, S.D.; Bagdi, A.K., I2-Catalyzed Three-Component Synthesis of 3-Selenylated Pyrazolo[1,5-a]pyrimidines, New Journal of Chemistry, (2024), https://doi.org/10.1039/D3NJ05847F (April 2024)

​​

  • Bag, D.; Sawant, S.D.,* Diastereoselective synthesis of functionalized spiroindolines via intramolecular ipso-iodocyclization/nucleophile addition cascade reactions of indole-tethered ynones, Organic & Biomolecular Chemistry (2024), 22, 3415- 3419 https://doi.org/10.1039/D4OB00112E (April 2024)

 

2023​

  • Ahmed, M.; Mahajan, S.; Kour, J.; Sawant, S.D.,* Sulfonylpyrazole and pyrazole directed ortho-selective C–H functionalization/alkenylation and desulfenylative olefination of aryl(sulfonyl)pyrazoles, Organic & Biomolecular Chemistry (2023), 21, 8301-8305 https://doi.org/10.1039/D3OB01262J (September 2023)

​

  • Bag, D.; Sawant, S.D.,* Ag(I)-Catalyzed Dearomatizing Spirocyclization/Nucleophile Addition Cascade Reactions of Indole-tethered Ynones, Chemical Communications, (2023), 59, 12649 - 12652. https://doi.org/10.1039/D3CC03543C  (September 2023)

​

  • Bag, D.; Kour, H.; Saha, N.; Kamal; Holla, H.; Bharatam, P.; Sawant, S.D.* Iodocycloisomerization/Nucleophile Addition Cascade Transformations of 1,2-Alkynediones, The Journal of Organic Chemistry (2023), 88, 4, 2377–2384. https://doi.org/10.1021/acs.joc.2c02790 (January 2023)

​

  • Hudwekar, A.D.; Kotwal, P.; Balgotra, S, Dogra, A.; Kour, J.; Chobe, S.S., Nandi, U.; Hussain, S.S., Sawant, S.D.,* Pyrazolopyrimidinone based selective inhibitors of PDE5 for the treatment of erectile dysfunction, Chemistry & Biodiversity (2023), 20(4), e202200707. https://doi.org/10.1002/cbdv.202200707 (April 2023)

​

  • Kumar, A.; Kour, D.; Ali, M.; Khajuria, P.; Sharma, K.; Ghosh, P.; Kaur, S.; Mahajan, S.; Ramajayan, P.; Bharate, S.S.; Bharadwaj, S.; Sawant, S.D.; Reddy, D.S.; Flurbiprofen inhibits heme induced NLRP3 inflammasome in sickle cell disease Berkeley mice; Front. Pharmacol. Sec. Inflammation Pharmacology, (2023), 14,1123734. https://doi.org/10.3389/fphar.2023.1123734  (April 2023)

​​

  • Gour, A.; Kour, D.; Ramajayan, P.; Bharadwaj, M.; Sawant, S.D.; Kumar, A.; Nandi, U.; Ellagic acid exerts dual action to curb the pathophysiological manifestations of sickle cell disease and attenuate the hydroxyurea-induced myelosuppression in Berkeley mice; ACS Pharmacol. Transl. Sci. (2023),  6, 6, 868–877. https://doi.org/10.1021/acsptsci.3c00026 (May 2023)

​

  • Jan, S.; Dar, M.I.; Gauri Shankar; Wani R.; Sandey, J.; Balgotra, S.; Mudassir, S.; Dar, M.J.; Sawant, S.D.; Akhter, Y.; Syed,  S.H.; Discovery of SDS-347 as a specific peptide competitive inhibitor of G9a with promising anti-cancer potential; Biochimica et Biophysica Acta(BBA) - General Subjects, (2023), 1867(9), 130399. https://doi.org/10.1016/j.bbagen.2023.130399 (June 2023)

​

2022

  • Kour, H.; Sharma, A.; Kour, J.; Ahmed, M.;  Sawant S.D.*, Green Approach for N‒H Functionalization of Sulfoximines: An Access to Sulfoximinated-Oxime Conjugates, European Journal of Organic Chemistry, (2022),  48, e202201375. https://doi.org/10.1002/ejoc.202201375  (December 2022)

 

  • Kour, J.; Khajuria, P.; Sharma,  A.; Sawant, S.D. *, TBAX/Oxone Mediated Halogenation of Pyrazoles and Other Heterocycles: An Entry to Important Cross Coupling Reactions, Chemistry: An Asian Journal (2022),  17(22), e202200778. https://doi.org/10.1002/asia.202200778  (September 2022)

​

  • Sharma, A.; Kour, H.; Kour, J.; Kamal,; Sawant, S.D.*, Visible-light-promoted iron catalyzed C‒H functionalization of 1,4-naphthoquinones via oxidative coupling with sulfoximines; Chemical Communications, (2022), 58, 11312-11315. https://doi.org/10.1039/D2CC03319D  (August 2022)

​

  • Mahajan, S.; Sawant, S.D.*, Iodine/TBHP-Mediated One-Pot Multicomponent Protocol for Tandem C−N and C−S Bond Formation To Access Sulfenylimidazo[1,5-a]pyridines via C−H Functionalization; The Journal of Organic Chemistry (2022) 87, 11387−11398, https://doi.org/10.1021/acs.joc.2c00890.  (August 2022)

​

  • Bag, D.; Sawant, S.D.*, Gold(I)-Catalyzed Cycloisomerization–Indole Addition Cascade: Synthesis of 3(2H)-Furanone-Incorporated Unsymmetrical 3,3′- Bis(indolyl)methanes, Organic Letters (2022), 24, 27, 4930-4934. https://doi.org/10.1021/acs.orglett.2c01845  (July 2022)

​

  • Khan, S.U.; Pathania, A.S.; Wani, A.;  Fatima, K.; Mintoo, M.J.; Hamza, B.; Paddar, M.A.; Wadhwa, B.; Anand, L.K.; Maqbool, M.S.; Mir, S.A.; Kour, J.; Venkateswarlu, V.; Mondhe, D.M.; Sawant, S.D.; Malik. F.; Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor. Scientific Reports (2022), 12, 5052. https://doi.org/10.1038/s41598-022-07955-1.  (April 2022)

 

  • Kour, J.; Khajuria, P.; Verma, P.K.; Kapoor, N.; Kumar, A.; Sawant, S.D.*, Selective Synthesis of Bis-Heterocycles via Mono- and Di-Selenylation of Pyrazoles and Other Heteroarenes, ACS Omega, (2022), 7, 15, 13000–13009. https://doi.org/10.1021/acsomega.2c00323.  (April 2022)

​

  • Behera, C.; Kour, J.;  Banjare, N.;  Verma, P.K.;  Chashoo, G.;  Sawant, S.D.;  Gupta, P.N.; Mechanistic investigation of synergistic interaction of tocopherol succinate with a quinoline-based inhibitor of mammalian target of rapamycin, Journal of Pharmacy and Pharmacology, (2022), 74(4), 605–617. https://doi.org/10.1093/jpp/rgab122.  (April 2022)

​​

  • Verma, P.K.;  Sawant, S.D.; Unravelling Reaction Selectivities via Bio-inspired Porphyrinoid Tetradentate Frameworks, Coordination Chemistry Reviews (2022), 450, 214239. https://doi.org/10.1016/j.ccr.2021.214239.  (January 2022)

​

2021

  • Bag, D.; Sawant, S.D.*, Heteroarene-tethered Functionalized Alkyne Metamorphosis, Chemistry-A European Journal (2021) 27(4), 1165-1218. https://doi.org/10.1002/chem.202002154. (January 2021)

 

2020

  • Bag, D.; Mahajan, S.; Sawant S.D.;*, Transition-Metal-Catalyzed Carbohalogenative 1,2-Difunctionalization of C-C Multiple Bonds, Advanced Synthesis & Catalysis (2020) 362, 3948– 3970. https://doi.org/10.1002/adsc.202000630  (October 2020)

 

  • Bag, D.; Verma, P.K.; Sawant S.D.*, Chiral Transient Directing Group Strategies in Asymmetric Synthesis, Chemistry: An Asian Journal (2020), 15, 3225–3238. https://doi.org/10.1002/asia.202000657  (October 2020)

 

  • Bag, D.; Kour, H.; Sawant S.D.*, Photo-induced 1,2-carbohalofunctionalization of C–C multiple bonds via ATRA pathway, Organic and Biomolecular Chem. (2020) 18, 8278–8293. https://doi.org/10.1039/D0OB01454K (September 2020)

​

  • Kour, J.; Venkateswarlu, V.; Verma, P.K.; Hussain, Y.; Dubey, G.; Bharatam, P.V.; Sahoo, S.C.; Sawant S.D.*;   Oxone-DMSO Triggered Methylene Insertion and C(sp2)—C(sp3)-H—C(sp2) Bond Formation to Access Functional Bis-Heterocycles. The Journal of Organic Chemistry (2020) 85, 7, 4951–4962. https://doi.org/10.1021/acs.joc.9b03477. (March 2020)

​

  • Dar, M.I.; Jan, S.; Reddy, G.L.; Wani, R.; Syed, M.; Dar, M.J.; Sawant, S.D.; Vishwakarma, R.A.;. Syed, S.H; Differentiation of human neuroblastoma cell line IMR-32 by sildenafil and its newly discovered analogue IS00384. Cellular Signalling  (2020) 65, 109425. https://doi.org/10.1016/j.cellsig.2019.109425  (January 2020)

​

  • Balgotra, S.; Verma, P.K.; Vishwakarma, R.A.; Sawant, S.D.*, Catalytic advances in direct functionalizations using arylated hydrazines as the building blocks. Catalysis Reviews (Taylor and Francis), (2020), 62(3), 406-479. https://doi.org/10.1080/01614940.2019.1702191  (September 2020)

​

2019

 

  • Reddy, G.L.;  Dar, M.I.; Hudwekar, A.D.; Mahajan, P.; Nargotra, A.;  Baba, A.M.; Nandi, U.; Wazir, P.; Singh, G.D.; Vishwakarma, R.A.; Hussain, S.S.; S.D. Sawant,* Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction Bioorganic Chemistry (2019), 89, 103022. https://doi.org/10.1016/j.bioorg.2019.103022  (August 2019)

​

  • Hudwekar, A.D.; Verma, P.K.; Kour, J.; Balgotra, S.; Sawant, S.D.*; Transition Metal-Free Oxidative Coupling of Primary Amines in Polyethylene Glycol at Room Temperature: Synthesis of Imines, Azobenzenes, Benzothiazoles, and Disulfides. European Journal of Organic Chemistry, (2019), 6, 1242–1250. https://doi.org/10.1002/ejoc.201801610  (December 2018)

​

2018

  • Venkateswarlu, V.; Kour, J.; Aravinda Kumar, K. A.; Verma, P.K.; Reddy, G. L.; Hussain, Y.; Tabassum, A.; Balgotra, S.; Gupta, S.; Hudwekar, A.D.; Vishwakarma, R.A.; Sawant, S.D.*; Direct N-heterocyclization of hydrazines to access styrylated pyrazoles: Synthesis of 1,3,5-trisubstituted pyrazoles and dihydropyrazoles, RSC Advances, (2018), 8, 26523-26527. https://doi.org/10.1039/C8RA04550J  (July 2018)

​

  • Balgotra, S.; Verma, P.K.; Kour, J.; Gupta, S.; Vishwakarma, R.A.; Sawant, S.D.*; A Novel Approach to Access Aryl Iodides and Disulfides via Dehydrazination of Arylhydrazines and Arylsulfonylhydrazides, ChemistrySelect (2018), 3, 2800–2804. https://doi.org/10.1002/slct.201800188  (March 2018)

​

  • Srinivas, M.; Pathania, A.S.; Mahajan, P.; Verma, P.K.; Chobe, S.S.; Malik, F.A.; Nargotra, A.; Vishwakarma, R.A.; Sawant, S.D.*; Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kc isoform selective activity, Bioorganic and Medicinal Chemistry Letters, (2018), 28, 1005-1010. https://doi.org/10.1016/j.bmcl.2018.02.032  (April 2018)

 

  • Aravinda Kumar, K. A.; Sawant, S.D.; Vishwakarma, R.A.; Design, synthesis and isoform selective PI3K inhibitory activity of modified B-ring Liphagal analogs, International Journal of Advance Research in Science and Engineering, (2018), 7(2), 571-581. DOI: 1519304786_SVCET2131ijarse.  (February 2018)

 

2017

  • Hudwekar, A.D.; Reddy, G.L.; Verma, P.K.; Gupta, S.; Vishwakarma, R.A.; Sawant, S.D.*; Transition Metal–free Single Step Approach for Arylated Pyrazolopyrimidinones and Quinazolinones Using Benzylamines/Benzylalcohols/Benzaldehydes; ChemistrySelect (2017), 2, 4963 –4968. https://doi.org/10.1002/slct.201700896  (June 2017)

 

 

  • Gul, T.; Haq, E.; Balkhi, H.M.; L.Reddy, G.; Sawant, S.D.;  Hamid, A.; Effect of combination of SAHA and THA on key metabolic regulatory proteins and adipocytes apoptosis in 3T3L1 preadipocytic cell line Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences (2017), 3(4), 49-60. DOI - 10.26479/2017.0304.05. 

 

2015

  • Venkateswarlu, V.; Aravinda Kumar, K. A.; Gupta, S.; Singh, D.; Vishwakarma R.; Sawant, S.D.*; DMSO/I2 mediated C‒C bond cleavage of α-ketoaldehydes followed by C‒O bond formation: A metal-free approach for one-pot esterification. Organic & Biomolecular Chemistry (2015), 13, 7973-7978. https://doi.org/10.1039/C5OB01015B (Most Accessed Article)  (June 2015)

 

  • Venkateswarlu, V.; Pathania, A.S.; Aravinda Kumar, K.A.; Mahajan, P.; Nargotra, A.; Vishwakarma, R. A.; Malik, F.A.; Sawant, S.D.* 4-(N-phenyl-N'-substituted benzenesulfonyl)-6-(4-hydroxyphenyl) quinolines as Inhibitors of Mammalian Target of Rapamycin. Bioorganic & Medicinal Chemistry (2015), 23(15), 4237-4247. https://doi.org/10.1016/j.bmc.2015.06.046  (August 2015)

 

  • Kumar, K.A.A.; Venkateswarlu, V.; Vishwakarma, R.A.; Sawant, S.D.* A metal-free approach to carboxylic acids by oxidation of alkyl, aryl or heteroaryl alkyl ketones and arylalkynes. Synthesis (2015), 47(20), 3161-3168. DOI: 10.1055/s-0034-1381026  (October 2015)

 

  • Raghupathy, R.; Ambika, A.; Polley, A.; Singh, P. P.; Yadav, M.; Johnson, C.; Suryawanshi, S.; Saikam, V.; Sawant, S.D.; Panda, A.; Guo, Z.; Vishwakarma, R.A.; Rao, M.; Mayor, S. Transbilayer Lipid Interactions Mediate Nanoclustering of Lipid-Anchored Proteins. Cell (2015), 161(3), 581-594. https://doi.org/10.1016/j.cell.2015.03.048 (April 2015)

 

  • Srinivas, M.; Hudwekar, A.D.; Venkateswarlu, V.; Reddy, G.L.; Aravinda Kumar, K. A.; Vishwakarma, R. A.; Sawant, S.D.* A metal-free approach for transamidation of amides with amines in aqueous media. Tetrahedron Letters (2015), 56(33), 4775–4779. https://doi.org/10.1016/j.tetlet.2015.06.052  (August 2015)

 

  • Gul, T., Balkhi, H.M., Reddy, G.L., Sawant, S.D., Hamid, A., Haq, E.; Effect of combination of suberoylanilide hydroxamic acid and O2’, O3’, O5’-tri-acetyl-N6-(3-hydroxyaniline)adenosine on various obesity related markers in 3T3-L1 pre-adipocytic cell line. International Journal of Biological & Pharmaceutical Research (2015), 6(10), 831-838. DOI:10.21276/ijbpr (October 2015)

 

  • Venkateswarlu, V.; Balgotra, S.; Vishwakarma, R.A.; Sawant, S.D.* Metal-free Chemoselective ortho-C(sp2)–F Bond Hydroxylation and N-trifluoroacylation of Fluoroarylamines for Domino Synthesis of N-trifluoroacyl-ortho-aminophenols. Synlett, (2015), 26, 1258–1262. DOI: 10.1055/s-0034-1379905  (June 2015)

 

  • Guru, S.K.; Venkateswarlu, V.; Malik, F.A.; Vishwakarma, R.A.; Sawant, S.D.*; Bhushan, S.; A novel quinoline based second-generation mTOR inhibitor that induces apoptosis and disrupts PI3K-Akt-mTOR signaling in human leukemia HL-60 cells. Anti-Cancer Agents in Medicinal Chemistry (2015), 15(10), 1297 – 1304. DOI: 10.2174/1871520615666150402093558  (January 2015)

 

  • Munagala, G.; Reddy Yempala, K.; Singh, S.; Sharma, S.; Kalia, N.P.; Singh, V.K.; Kumar, S.; Sawant, S. D.; Khan, I. A.; Vishwakarma, R.A.; Singh, P.P. Synthesis of new generation triazolyl and isoxazolyl containing 6-nitro-2,3-dihydroimidazooxazoles as anti-TB agents: In vitro, Structure-activity relationship, pharmacokinetics and in vivo evaluation. Organic & Biomolecular Chemistry (2015), 13, 3610-3624. https://doi.org/10.1039/C5OB00054H  (March 2015)

 

  • Balgotra, S.; Venkateswarlu, V.; Vishwakarma, R.A.; Sawant, S.D.* Direct C‒N bond cleavage of N-vinyl or N-allyl arylamines: A metal-free strategy for N-devinylation and N-deallylation. Tetrahedron Letters (2015), 56, 4289–4292. https://doi.org/10.1016/j.tetlet.2015.05.042  (July 2015)

 

  • Sawant, S.D.*; Reddy, G.L.; Dar, I.M.; Srinivas, M.; Gupta, G.; Sahu, P.K.; Mahajan, P.; Singh, S.; Sharma, S.C.; Tikoo, M.; Singh, G.D.; Nargotra, A.; Vishwakarma, R.A.; Syed, S.H. Discovery of Novel Pyrazolopyrimidinone Analogs as Potent Inhibitors of Phosphodiesterase Type-5. Bioorganic & Medicinal Chemistry (2015), 23(9), 2121-2128. https://doi.org/10.1016/j.bmc.2015.03.005  (May 2015)

 

2014

  • Reddy, G. L.; Guru, S. K.; Srinivas, M.; Pathania, A.S.; Mahajan, P.; Nargotra, A.; Bhushan, S.; Vishwakarma, R.A.; Sawant, S.D.* Synthesis of 5-substituted-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one analogs and their biological evaluation as anticancer agents: mTOR inhibitors. European Journal of Medicinal Chemistry (2014), 10(80), 201-208. https://doi.org/10.1016/j.ejmech.2014.04.051  (June 2014)

 

  • Venkateswarlu, V.; Aravinda Kumar, K. A.; Balgotra, S.; Reddy, G. L.; Srinivas, M.; Vishwakarma, R. A.;  Sawant, S.D.,*  C‒H Oxygenation and N-Trifluoroacylation of Arylamines under Metal-Free Conditions: A Convenient Approach to 2-Aminophenols and N-Trifluoroacyl-ortho-aminophenols. Chemistry: A European Journal (2014), 20(22),  6641–6645. https://doi.org/10.1002/chem.201402411  (May 2014)

 

  • Yadav, M.; Raghupathy, R.; Saikam, V.; Dara, S.; Singh, P.P.; Sawant, S.D.; Mayor, S.; Vishwakarma, R. A.; Synthesis of non-hydrolysable mimics of glycosylphosphatidylinositol (GPI) anchors. Organic & Biomolecular Chemistry (2014), 12, 1163. DOI: 10.1039/C3OB42116C (December 2013)

 

  • Sawant, S.D.*; Hudwekar, A.D.; Aravinda Kumar, K.A.; Venkateswarlu, V.; Singh, P.P.; Vishwakarma, R. A. Ligand- and base-free synthesis of phenols by rapid oxidation of arylboronic acids using iron(III) oxide. Tetrahedron Letters (2014), 55, 811-814. https://doi.org/10.1016/j.tetlet.2013.12.003 (Article Highlighted in SYNFACTS for its important insights; Oxidation of ArB(OH)2 using Fe2O3 under solar VIS-light irradiation, Synfacts 2014; 10(4): 0445. DOI: 10.1055/s-0033-1340906).  (January 2014)

 

2013

  • Bharate, S.B.; Sawant, S.D.; Singh, P.P.; Vishwakarma, R.A.; Kinase Inhibitors from Marine Origin. Chemical Reviews (2013), 113(8), 6761–6815. https://doi.org/10.1021/cr300410v  (May 2013)

 

 

  • Khazir, J.; Singh, P.P.; Reddy, D.M.; Hyder, I.; Shafi, S.; Sawant, S.D.; Chashoo, G.; Mahajan, A.; Alam, M.S.; Saxena, A.K..; Arvinda, S.; Gupta, B.D.; Sampath Kumar, H. M. Synthesis and anticancer activity of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of α-santonin, European Journal of Medicinal Chemistry (2013), 63, 279-289. https://doi.org/10.1016/j.ejmech.2013.01.003  (May 2013)

 

  • Sawant, S.D.*; Srinivas, M.; Reddy, G.L.; Venkateswarlu, V.; Singh, P.P.; Vishwakarma, R.A. One-pot multicomponent synthesis of medicinally important purine quinazolinone derivatives. Tetrahedron Letters (2012), 53, 6195–6198. https://doi.org/10.1016/j.tetlet.2012.08.137  (November 2012)

 

2012

  • Singh, P.P.; Thatikonda, T.; Aravinda Kumar, K.A.; Sawant, S.D.; Singh, B.; Sharma, A.K.; Sharma, P. R.; Singh, D.; Vishwakarma, R.A. Cu-Mn Spinel Oxide Catalyzed Regioselective Halogenation of Phenols and N-Heteroarenes. The Journal of Organic Chemistry (2012), 77, 5823-5828. https://doi.org/10.1021/jo300731z  (June 2012)

 

  • Singh, P.P.; Gudup, S.; Aruri, H.; Singh, U.; Ambala, S.; Yadav, M.; Sawant S.D.; Vishwakarma, R. A. New method for C-H arylation/alkylation at α-position of cyclic aliphatic ethers by iron-oxide mediated reaction. Organic & Biomolecular Chemistry (2012), 10, 1587. DOI: 10.1039/C1OB06660A   (January 2012)

 

2011

  • Reddy, D. M.; Qazi N. A.; Sawant, S. D.; Banday, A. H.; Jada S.; Mannepalli S.; Singh, S. K.; Verma, M.; Chashoo, G.; Saxena A.; Mondhe D. M.; Saxena, A. K.; Sethi, V. K.; Taneja, S. C.; Qazi, G. N.; Sampath Kumar, H. M. Design and synthesis of spiro derivatives of parthenin as novel anti-cancer agents. European Journal of Medicinal Chemistry (2011), 46, 3210-3217. https://doi.org/10.1016/j.ejmech.2011.04.030  (August 2011)

 

  • Singh, P.P.; Gudup, S.; Ambala, S.; Singh, U.; Dadhwal, S.; Singh, B.; Sawant, S.D.; Vishwakarma, R.A. Iron-oxide mediated direct C−H arylation/alkylation at α-position of cyclic aliphatic ethers. Chemical Communication (2011), 47, 5852–5854. DOI: 10.1039/C1CC11094B (Published as Hot Article for ChemComm)  (April 2011)

 

  • Saikam, V.; Yadav, M.; Gannedi, V.; Raghupathy, R.; Singh, P.P.; Qazi, N.A.; Sawant S.D.; Vishwakarma, R. A. Synthesis of new fluorescence labeled GPI anchors. Tetrahedron Letters (2011), 52, 4277-4279. https://doi.org/10.1016/j.tetlet.2011.06.005  (August 2011)

 

Before 2010

  • Ismail T.; Shafi S.; Singh P.P.; Qazi N.A.; Sawant S.D.; Khan I.A.; Kumar H.M.S.; Qazi G.N.; Alam M.S.; Synthesis and biological activity of hydroximoyl chlorides as antifungal agents. Indian Journal of Chemistry Sec. B Org Chem. Med. Chem. (2008), 47B, 740. http://hdl.handle.net/123456789/1728  (May 2008)

 

  • Sawant, S. D.; Singh, P.P.; Qazi, N.A.; Kumar, H.M.S. Addition of Allylindium Bromide to Nitrile Oxides in Aqueous Media: Convenient Synthesis of 5-Methylisoxazolines. Chemistry Letters (2007), 36, 2, 296-297. https://doi.org/10.1246/cl.2007.296  (January 2007)

 

  • Singh, P.P.; Reddy, P.B.; Sawant, S.D.; Koul, S.; Taneja, S.C.; Sampath Kumar, H.M. Domino synthesis of indenols and alkyl-indene ethers under modified Vilsmeier conditions. Tetrahedron Letters (2006), 47, 7241–7243. https://doi.org/10.1016/j.tetlet.2006.07.126  (October 2006)

 

  • Reddy, P.B.; Singh, P.P.; Sawant, S.D.; Koul, S.; Taneja, S.C.; Sampath Kumar, H.M. Microwave promoted novel synthesis of indenols catalyzed by SiO2 in dry media. ARKIVOC (2006) (xiii), 142-146. http://dx.doi.org/10.3998/ark.5550190.0007.d14  (September 2006)

 

  • Sampath Kumar, H.M.; Chakravarthy, P.; Sawant, S.D.; Singh, P.P.; Shesha Rao M.; Yadav, J.S. Catalytic transfer hydrogenation reactions on PEG-bound succinyl esters. Tetrahedron Letters (2005), 46, 3591-3593. https://doi.org/10.1016/j.tetlet.2005.03.031  (May 2005)

​

Books/Book Chapters

  • D. Bag, A. Tabassum, N. Arora, P.K. Verma, S.D. Sawant,* Medicinal Applications of Cannabidiol from the Genus Cannabis L.; A Book Chapter in 'Botanical Leads for Drug Discovery', Sringer Nature, 2020, DOI:10.1007/978-981-15-5917-4_10; ISBN 978-981-15-5916-7.​

  • J. Kour, S. Balgotra, P. Rajput, H. Kour, P.K. Verma, S.D. Sawant,* Medicinal Value of High-Altitude Plants of Indian Himalaya; A Book Chapter in 'Botanical Leads for Drug Discovery', Sringer Nature, 2020, DOI: 10.1007/978-981-15-5917-4_14; ISBN 978-981-15-5916-7.

  • P.K. Verma, A. Tabassum and S.D. Sawant,* Medicinal Importance of Artemisia annua L. and Discovery of Artemisinin; Plants of Commercial Values; 2019, pp 167-181; New India Publishing Agency, New Delhi, India, CRC Press ISBN 9780367819361

​

Patents

  • Cham, P.S.; Singh, M.; Verma, A.; Anand, R.; Singh, R.; Sharma, K.; Kotwal, P.; Gour, A.; Kumar, P.; Mindala, D.P.; Roy, S.; Singh, C.P.; Meena, S.R.; Kumar, A.; Verma, M.K.; Rahul, V.P.; Nandi, U.; Gairola, S.; Katare, A. K.; Singh, D.; Sangwan, P.L.; Vyas, D.; Sawant, S.D.; Singh, G.D.; Vishwakarma, R.A.; Reddy D.S.; and Singh, P.P.; Process of phytocannabinoids enrichment, its formulation and use in the   management of pain.(NF No.=0178NF2021)

  • Sawant, S.D.; Reddy, G.L.; Srinivas, M.; Hussain, S.S.; Dar, M.I.; Nargotra, A.; Mahajan, P.; Vishwakarma, R.A. Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof. (WO 2015/114647 A1, 08/2015)

  • Sawant, S.D.; Reddy, G.L.; Srinivas, M.; Hussain, S.S.; Dar, M.I.; Nargotra, A.; Mahajan, P.; Vishwakarma, R.A., Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof ; US15/115,573 (Date of filing: 2014-01-30; Date of grant: 2018-07-10 ; Expiry: 2034-10-20)

  • Sawant, S.D.; Reddy, G.L.; Srinivas, M.; Hussain, S.S.; Dar, M.I.; Nargotra, A.; Mahajan, P.; Vishwakarma, R.A., Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof ; EP3099689B1 (Date of filing: 2014-10-20; Date of grant: 2022-01-26 ; Expiry: 2034-10-20)

  • Sawant, S.D.; Reddy, G.L.; Srinivas, M.; Hussain, S.S.; Dar, M.I.; Nargotra, A.; Mahajan, P.; Vishwakarma, R.A.; Novel pyrazolopyrimidinones for the treatment of impotence and process for preparation thereof , IN2014DE00281A (Date of filing: 2014-10-20; Date of publication: 2022-08-07)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A.; 6-Nitro-2,3-dihydroimidazo[2,1-b]oxazoles and process for the preparation thereof. (WO2015/049693A1, 04/2015)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A.; 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof, IN2954DE2013; (Date of filing: 2014-03-31; Date of publication: 2015-04-10)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A.; 6-nitro-2,3-dihydroimidazo [2,1-b] oxazoles and a method of preparing them; ES2707362T3 (Date of filing: 2014-03-31; Date of grant: 2019-04-03 ; Expiry: 2034-03-31)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A.; 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof; EP3052503B1; (Date of filing: 2014-03-31; Date of grant: 2018-10-24 ; Expiry: 2034-03-31)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A., 6-Nitro-2,3-dihydroimidazo [2,1-b] oxazoles and processes for their preparation; JP6532457B2; (Date of filing: 2014-03-31; Date of grant: 2019-06-19 ; Expiry: 2034-03-31)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A.; 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof; US9845330B2; (Date of filing: 2014-03-31; Date of grant: 2017-12-19 ; Expiry: 2034-03-31)

  • Singh, P.P.; Munagala G.; Reddy Yempala, K.; Khan, I.A.; Kalia, N.P.; Singh Rajput, V.; Nargotra, A.; Sawant, S.D.; Vishwakarma, R.A.; 6-nitro-2,3-dihydroimidazo[2,1-b]oxazole and preparation method thereof; TWI654192B; (Date of filing: 2014-06-13; Date of grant: 2019-03-21)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N. Boronic acid bearing liphagane compounds as PI3K-alpha/beta inhibitors. (WO 2013/140147 A1)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N. Boronic acid bearing liphagane compounds as PI3K-alpha/beta inhibitors; US9206201B2; (Date of filing: 2013-03-18; Date of grant: 2015-12-08 ; Expiry: 2033-03-18)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N.; With the LIPHAGANE compound of boric acid as the inhibitor of PI3K-α and/or β; CN104395325B; (Date of filing: 2013-03-18; Date of grant: 2016-12-07 ; Expiry: 2033-03-18)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N.; Rifagain compound with boronic acid as an inhibitor of PI3K-α and / or β; JP6126197B2; (Date of filing: 2013-03-18; Date of grant: 2017-05-10 ; Expiry: 2033-03-18)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N.; Boronic acid bearing liphagane compounds as inhibitors of pi3k-alpha and/or beta; EP2828269B1; (Date of filing: 2013-03-18; Date of grant: 2018-05-16; Expiry: 2033-03-18)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N.; Boronic acid bearing liphagane compounds as inhibitors of pi3k-.alpha. and/or .beta.; CA2867452C; (Date of filing: 2013-03-18; Date of grant: 2020-04-14; Expiry: 2033-03-18)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N.; ANALOGS OF LIPHAGANE SCAFFOLD AND PROCESS FOR PREPARATION THEREOF; IN2012DE00794A; (Date of filing: 2013-03-18; Date of publication: 2015-08-21)

  • Vishwakarma, R.A.; Sawant S.D.; Singh P.P.; Dar A.H.; Sharma P.R.; Saxena A.K.; Nargotra A.; Aravind Kumar K.A.; Ramesh, M.; Qazi A.K.; Hussain A.; Chanauria N.; Boronic acid bearing liphagane compounds as inhibitors of pi3k-α and/or β; TWI577687B; (Date of filing: 2013-03-19; Date of grant: 2017-04-11)

  • Kumar, H.M.S.; Sawant, S.D.; Qazi, N.A.; Singh, S.K.; Verma, M.; Saxena, A.K.; Sethi, V.K.; Taneja, S.C.; Qazi, G.N. Spiro-derivatives of parthenin as novel anticancer agents (WO/2009/110007A8)

  • Kumar, H.M.S.; Saxena, A.K.; Taneja, S.C.; Singh, S.K.; Sethi, V.K.; Qazi, N.A.; Sawant, S.D. Reddy, D.M.;, Banday, A.H.; Verma, M.; Qazi, G.N.; Spiro derivatives of parthenin as novel anticancer agents; US 2011/0201661 A1; (Patent Expired)

  • Kumar, H.M.S.; Saxena, A.K.; Taneja, S.C.; Singh, S.K.; Sethi, V.K.; Qazi, N.A.; Sawant, S.D. Reddy, D.M.;, Banday, A.H.; Verma, M.; Qazi, G.N.; Spiro derivatives of parthenin as novel anticancer agents; EP2265620 A1; (Patent Expired)

  • Kumar, H.M.S.;, Saxena, A.K.; Taneja, S.C.; Singh, S.K.; Sethi, V.K.; Qazi, N.A.; Sawant, S.D. Reddy, D.M.;, Banday, A.H.; Verma, M.; Qazi, G.N.;; Spiro derivatives of parthenin as novel anticancer agents; JP5864107B2; (Date of filing: 2009-03-05; Date of grant: 2011-03-28)

  • Kumar, H.M.S.;, Saxena, A.K.; Taneja, S.C.; Singh, S.K.; Sethi, V.K.; Qazi, N.A.; Sawant, S.D. Reddy, D.M.;, Banday, A.H.; Verma, M.; Qazi, G.N.; Spiro derivatives of parthenin as novel anticancer agents; CA2728855C; (Date of filing: 2009-03-05; Date of grant: 2017-02-07)

  • Kumar, H.M.S.;, Saxena, A.K.; Taneja, S.C.; Singh, S.K.; Sethi, V.K.; Qazi, N.A.; Sawant, S.D. Reddy, D.M.;, Banday, A.H.; Verma, M.; Qazi, G.N.;  Spiro derivatives of parthenin as novel anticancer agents; RU2499798C2; (Date of filing: 2009-03-05; Date of grant: 2013-11-27)

  • Kumar, H.M.S.; Sawant, S.D.; Reddy, D.M.; Banday, A.H.; Qazi, G.N. Novel hybrids of perfumery molecules with extremolytes, humectants and exfoliating agents for the development of new generation multiple action skin/beauty care bio-conjugates; (Indian patent 0656DEL2009; 785/DEL/2010 A; 786/DEL/2010 A; 787/DEL/2010 A. Indian patent No. 274883

  • Kumar, H.M.S.; Qazi, N.A.; Sawant, S.D.; Singh, P.P.; Syed, S.; Taneja, S.C.; Khajuria, A.; Gipta, A.; Bani, S.; Qazi, G.N. 5-butyl isoxazolines as novel immunomodulators (Indian patent 844/DEL/2006; 13/2012)

  • Kumar, H.M.S.; Sawant S.D.; Process for preparation of hybrid conjugates; 783/DEL/2010

  • Kumar, H.M.S.; Sawant, S.D.; Qazi, N.A.; Singh, S.K.; Verma, M.; Saxena, A.K.; Sethi, V.K.; Taneja, S.C.; Qazi, G.N.; Novel spiro derivatives of parthenin; 527/DEL/2008

bottom of page